Delivery Order SPE2DB22D3301-SPE2DB24FY3NC
Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $2.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML medical products. The contract has a firm fixed price of $2,549.46 and a period of performance through June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a potential value of $1,176.68 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
- The Defense Logistics Agency (DLA) awarded a $3,195.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,136.44 firm fixed-price delivery order is for the medical product "ENGERIX-B 20 MCG/ML VIALML" and has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product ENGERIX-B 20 MCG/ML VIALML, with a potential value of $1,860.24 and a completion date of January 9, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards to supply pharmaceuticals, medical supplies, and related...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,860.24 order is for the supply of ENGERIX-B 20 MCG/ML VIAL/ML, a pharmaceutical product. The order has a completion date of January 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. This delivery order is part of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML VIAL/ML pharmaceutical products. The $1,840.57 award has a completion date of February 23, 2024 and was issued on February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this order. Amerisourcebergen Drug Corp holds an...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $59,981.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,310,939 units of the ENGERIX-B 20 MCG/ML SYRNML pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,820.64 award is for the supply of ENGERIX-B 20 MCG/ML VIALML, a hepatitis B vaccine. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen Drug Corp to provide a comprehensive range of...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $76,007.40. This delivery order contract has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and the award does not have a set-aside designation. The...